Recent advancements in biology have unveiled the intricate relationship between the microbiota and various diseases, offering unprecedented opportunities for early detection, personalized treatment, and preventive measures.
Antimicrobial antibodies contribute to the diagnosis of inflammatory bowel diseases. Miniaturization and combination of assays are leading to the generation of a larger data set and thus to the immune profile of the antimicrobiome.
A state-of-the-art solution to monitor chronic inflammatory bowel diseases (IBD)
The Intest solution developed by Innobiochips takes advantage of the antibody fingerprint to help monitor chronic inflammatory bowel diseases (IBD): Crohn's disease and ulcerative colitis.
Our high-resolution multiplex technology can characterize anti-microbiota antibodies and generate a much larger data set to obtain the immune profile of the antimicrobiome.